---
figid: PMC5579385__MOL2-11-1273-g008
figtitle: MEK inhibitors suppress ERK‐mediated HER2 Thr701 phosphorylation to enhance
  clathrin‐dependent HER2/EGFR dimerization and subsequent Akt activation
organisms:
- NA
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC5579385
filename: MOL2-11-1273-g008.jpg
figlink: /pmc/articles/PMC5579385/figure/mol212102-fig-0008/
number: F8
caption: MEK inhibitors suppress ERK‐mediated HER2 Thr701 phosphorylation to enhance
  clathrin‐dependent HER2/EGFR dimerization and subsequent Akt activation. ERK1/2
  activated by RTK/MEK signaling axis feedback phosphorylates HER2 and EGFR at Thr701
  and Thr669, respectively, in response to EGF stimulation. HER2 Thr701 phosphorylation
  negatively regulates the heterodimerization of EGFR and HER2 via reducing the clathrin‐binding
  activity of HER2, resulting in the clathrin‐mediated endocytosis of EGFR homodimer
  to attenuate EGF signaling. Suppression of ERK activity by MEK inhibitors relieves
  the negative regulation on the clathrin‐dependent heterodimerization of HER2 and
  EGFR by reducing HER2 Thr701 phosphorylation. The increased binding between EGFR
  and HER2 enhanced and prolonged the activation of these RTKs and the downstream
  PI3K/Akt pathway, and may thereby contribute to the drug resistance to MEK inhibitors.
papertitle: MEK inhibitors induce Akt activation and drug resistance by suppressing
  negative feedback ERK‐mediated HER2 phosphorylation at Thr701.
reftext: Chia‐Hung Chen, et al. Mol Oncol. 2017 Sep;11(9):1273-1287.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9725488
figid_alias: PMC5579385__F8
figtype: Figure
redirect_from: /figures/PMC5579385__F8
ndex: c26f460a-dec4-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5579385__MOL2-11-1273-g008.html
  '@type': Dataset
  description: MEK inhibitors suppress ERK‐mediated HER2 Thr701 phosphorylation to
    enhance clathrin‐dependent HER2/EGFR dimerization and subsequent Akt activation.
    ERK1/2 activated by RTK/MEK signaling axis feedback phosphorylates HER2 and EGFR
    at Thr701 and Thr669, respectively, in response to EGF stimulation. HER2 Thr701
    phosphorylation negatively regulates the heterodimerization of EGFR and HER2 via
    reducing the clathrin‐binding activity of HER2, resulting in the clathrin‐mediated
    endocytosis of EGFR homodimer to attenuate EGF signaling. Suppression of ERK activity
    by MEK inhibitors relieves the negative regulation on the clathrin‐dependent heterodimerization
    of HER2 and EGFR by reducing HER2 Thr701 phosphorylation. The increased binding
    between EGFR and HER2 enhanced and prolonged the activation of these RTKs and
    the downstream PI3K/Akt pathway, and may thereby contribute to the drug resistance
    to MEK inhibitors.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGFR
  - ERBB2
  - CLTA
  - CLTB
  - CLTC
  - EGF
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MAPK3
  - MAPK1
  - AKT1
  - AKT2
  - AKT3
  - Egfr
  - Dsor1
  - Mtk
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - rl
  - Akt
  - tyrosine
---
